These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8926085)

  • 1. Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908.
    Barry EM; Gomez-Duarte O; Chatfield S; Rappuoli R; Pizza M; Losonsky G; Galen J; Levine MM
    Infect Immun; 1996 Oct; 64(10):4172-81. PubMed ID: 8926085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guérin producing a pertussis toxin-tetanus toxin hybrid protein.
    Abomoelak B; Huygen K; Kremer L; Turneer M; Locht C
    Infect Immun; 1999 Oct; 67(10):5100-5. PubMed ID: 10496883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.
    Galen JE; Gomez-Duarte OG; Losonsky GA; Halpern JL; Lauderbaugh CS; Kaintuck S; Reymann MK; Levine MM
    Vaccine; 1997; 15(6-7):700-8. PubMed ID: 9178472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific lung mucosal and systemic immune responses after oral immunization of mice with Salmonella typhimurium aroA, Salmonella typhi Ty21a, and invasive Escherichia coli expressing recombinant pertussis toxin S1 subunit.
    Walker MJ; Rohde M; Timmis KN; Guzmán CA
    Infect Immun; 1992 Oct; 60(10):4260-8. PubMed ID: 1398937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA.
    Orr N; Galen JE; Levine MM
    Vaccine; 2001 Feb; 19(13-14):1694-700. PubMed ID: 11166893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of fragment C of tetanus toxin fused to a carboxyl-terminal fragment of diphtheria toxin in Salmonella typhi CVD 908 vaccine strain.
    Gómez-Duarte OG; Galen J; Chatfield SN; Rappuoli R; Eidels L; Levine MM
    Vaccine; 1995 Nov; 13(16):1596-602. PubMed ID: 8578848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein.
    Boucher P; Sato H; Sato Y; Locht C
    Infect Immun; 1994 Feb; 62(2):449-56. PubMed ID: 7507893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters.
    Roberts M; Li J; Bacon A; Chatfield S
    Infect Immun; 1998 Jul; 66(7):3080-7. PubMed ID: 9632569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface expression of a protective recombinant pertussis toxin S1 subunit fragment in Streptococcus gordonii.
    Lee SF; March RJ; Halperin SA; Faulkner G; Gao L
    Infect Immun; 1999 Mar; 67(3):1511-6. PubMed ID: 10024603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and immunogenicity in mice of attenuated Salmonella typhi expressing Plasmodium falciparum merozoite surface protein 1 (MSP-1) fused to tetanus toxin fragment C.
    Wu S; Beier M; Sztein MB; Galen J; Pickett T; Holder AA; Gómez-Duarte OG; Levine MM
    J Biotechnol; 2000 Sep; 83(1-2):125-35. PubMed ID: 11000468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetanus toxin fragment C-specific priming by intranasal infection with recombinant Bordetella pertussis.
    Reveneau N; Alonso S; Jacob-Dubuisson F; Mercenier A; Locht C
    Vaccine; 2001 Dec; 20(5-6):926-33. PubMed ID: 11738759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A.
    Ward SJ; Douce G; Figueiredo D; Dougan G; Wren BW
    Infect Immun; 1999 May; 67(5):2145-52. PubMed ID: 10225867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal and systemic immune responses elicited by recombinant Lactococcus lactis expressing a fusion protein composed of pertussis toxin and filamentous hemagglutinin from Bordetella pertussis.
    Torkashvand A; Bahrami F; Adib M; Ajdary S
    Microb Pathog; 2018 Jul; 120():155-160. PubMed ID: 29738814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetanus toxin fragment C expressed in live Salmonella vaccines enhances antibody responses to its fusion partner Schistosoma haematobium glutathione S-transferase.
    Lee JJ; Sinha KA; Harrison JA; de Hormaeche RD; Riveau G; Pierce RJ; Capron A; Wilson RA; Khan CM
    Infect Immun; 2000 May; 68(5):2503-12. PubMed ID: 10768937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers.
    Capozzo AV; Cuberos L; Levine MM; Pasetti MF
    Infect Immun; 2004 Aug; 72(8):4637-46. PubMed ID: 15271924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior immunity to homologous and heterologous Salmonella serotypes suppresses local and systemic anti-fragment C antibody responses and protection from tetanus toxin in mice immunized with Salmonella strains expressing fragment C.
    Roberts M; Bacon A; Li J; Chatfield S
    Infect Immun; 1999 Aug; 67(8):3810-5. PubMed ID: 10417142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a pertussis toxin S1 fragment by inducible promoters in oral Streptococcus and the induction of immune responses during oral colonization in mice.
    Mallaley PP; Halperin SA; Morris A; MacMillan A; Lee SF
    Can J Microbiol; 2006 May; 52(5):436-44. PubMed ID: 16699568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a diphtheria toxin A fragment-C180 peptide fusion protein which elicits a neutralizing antibody response against diphtheria toxin and pertussis toxin.
    Barbieri JT; Armellini D; Molkentin J; Rappuoli R
    Infect Immun; 1992 Dec; 60(12):5071-7. PubMed ID: 1452339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella.
    Khan CM; Villarreal-Ramos B; Pierce RJ; Riveau G; Demarco de Hormaeche R; McNeill H; Ali T; Fairweather N; Chatfield S; Capron A
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11261-5. PubMed ID: 7972044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C.
    Tacket CO; Galen J; Sztein MB; Losonsky G; Wyant TL; Nataro J; Wasserman SS; Edelman R; Chatfield S; Dougan G; Levine MM
    Clin Immunol; 2000 Nov; 97(2):146-53. PubMed ID: 11027455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.